Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer

[11] Quasthoff S(1994)Differences in behaviour of sensory and motor axons following release of ischaemia Brain 117 225-2066

[12] Leonard GD(1999)Potassium current suppression in patients with peripheral nerve hyperexcitability Brain 122 2057-830

[13] Wright MA(1999)Strength-duration properties of peripheral nerve in acquired neuromyotonia Muscle Nerve 22 823-246

[14] Quinn MG(1997)Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia Ann Neurol 41 238-657

[15] Harold N(2000)Understanding neuromyotonia Muscle Nerve 23 655-216

[16] Schuler B(2000)Acquired neuromyotonia. A new autoantibody-mediated neuronal potassium channelopathy Am J Med Sci 319 209-1774

[17] Thomas RR(2002)Acute oxaliplatin-induced peripheral nerve hyperexcitability J Clin Oncol 20 1767-151

[18] Grem JL(2006)Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity Clin Colorectal Cancer 6 146-141

[19] Lehky TJ(2000)Oxaliplatin-induced neuropathy: could gabapentin be the answer Proc Am Soc Clin Oncol 19 609-120

[20] Leonard GD(2003)Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C Pain 105 133-263

[11] Quasthoff S(1994)Differences in behaviour of sensory and motor axons following release of ischaemia Brain 117 225-2066

[12] Leonard GD(1999)Potassium current suppression in patients with peripheral nerve hyperexcitability Brain 122 2057-830

[13] Wright MA(1999)Strength-duration properties of peripheral nerve in acquired neuromyotonia Muscle Nerve 22 823-246

[14] Quinn MG(1997)Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia Ann Neurol 41 238-657

[15] Harold N(2000)Understanding neuromyotonia Muscle Nerve 23 655-216

[16] Schuler B(2000)Acquired neuromyotonia. A new autoantibody-mediated neuronal potassium channelopathy Am J Med Sci 319 209-1774

[17] Thomas RR(2002)Acute oxaliplatin-induced peripheral nerve hyperexcitability J Clin Oncol 20 1767-151

[18] Grem JL(2006)Addition of gabapentin to a modified FOLFOX regimen does not reduce oxaliplatin-induced neurotoxicity Clin Colorectal Cancer 6 146-141

[19] Lehky TJ(2000)Oxaliplatin-induced neuropathy: could gabapentin be the answer Proc Am Soc Clin Oncol 19 609-120

[20] Leonard GD(2003)Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C Pain 105 133-263